Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.86 USD | -0.06% | +8.08% | +13.23% |
04-18 | Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing | MT |
04-10 | ALX Oncology Reports Positive Data From Ongoing Phase 1/2 Trial of Evorpacept | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- ALXO Stock
- News ALX Oncology Holdings Inc.
- Official Publications